Skip to main content

Table 2 Localized markers for differentiating ALI/ARDS from CPE

From: A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema

Study

Design

No. of ALI/ARDS vs CPE

Marker

Timing of measurement

Mean value ± SD/SEM or median (IQR or range) in ALI/ARDS

Mean value ± SD/SEM or median (IQR or range) in CPE

Unit

p value

AUC

95% CI

Cutoff

For

Specificity (%)

Sensitivity (%)

Markers of airway epithelium injury

Katayama, 2010*

Prospective

21 vs 11

Laminin gannma2 in ELF

Not stated

6034 ± 6245 SD

1237 ± 807 SD

ng/mL

<0.02

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

   

Laminin gannma2 in plasma

 

147 ± 83 SD

35 ± 14 SD

ng/mL

<0.0001

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Kropski, 2009*

Prospective

23 vs 9

CCP 16 in PEF

Within 24 h of diagnosis

1950 (IQR1780–4024)

4835 (IQR2006–6350)

ng/mL

0.044

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

   

CCP 16 in serum

 

22 (IQR9–44)

55 (IQR18–123)

ng/mL

0.053

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Chandel, 2009*

Prospective

15 vs 5

KGF in BAL

Within 48 h after intubation

1.2-fold ±0.12 SD

2.4-fold ±0.48 SD

fold

<0.01

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Newman, 2000*

Prospective

15 vs 12

HTI56 in PEF

Within 15 min after intubation

1451 ± 6 727

335 ± 123

ug/mL

<0.0001

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

   

HTI56 in plasma

 

217 ± 79

335 ± 123

ug/mL

<0.05

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Shimura,1996*

Prospective

5 vs 11

SP-A in sputum

Not stated

311 ± 47 SEM

1324 ± 197 SEM

ug/mL

<0.001

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Gunther, 1996*

Prospective

15 vs 13

SP-A in BAL

Within 72 h after intubation

849 ± 96 SEM

1013 ± 111 SEM

ng/mL

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

   

SP-B in BAL

 

867 ± 131 SEM

628 ± 42 SEM

ng/mL

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Protein ratio of fluid to plasma

Ware, 2010***

Prospective

209 vs 147

Fluid-to-plasma protein ratio

Not stated

0.89 ± 0.36 SD

0.53 ± 0.21 SD

n.d.

<0.001

0.84

0.79-0.88

0.65

ALI/ARDS

81

81

Colucci, 2009*

Prospective

18 vs 9

Protein ratio of fluid by s-Cath to plasma

Within 1–4 h after intubation

Prim. 0.32 ± 0.42 SD, Sec. 0.81 ± 0.33 SD

0.20 ± 0.19 SD

n.d.

0.002 in Sec. vs CPE

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Schutte, 1996*

Prospective

12 vs 6

Protein in BAL

Within 72 h after intubation

671 ± 256 SEM

291 ± 81 SEM

ug/mL

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

   

PMN in BAL

 

16.1 ± 5.8 SEM

0.4 ± 0.11 × 10^6

/mL

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

   

Serum CRP*

 

235 ± 33 SEM

93 ± 25 SEM

mg/L

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Miller, 1996*

Prospective

27 vs 8

Protein in PEF/plasma

Within 30 min after intubation

0.90 ± 0.09 SEM in w/o sepsis, 0.84 ± 0.16 SEM in w sepsis,

0.48 ± 0.12 SEM

Ratio

<0.05

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

Others

Kushimoto, 2012***

Prospective

207 vs 26

EVWI

Not stated

18.5 ± 6.8 SD

14.4 ± 4.0 SD

mL/kg

<0.01

n.d.

n.d.

n.d.

n.d.

n.d.

n.d.

   

PVPI

 

3.2 ± 1.4 SD

2.0 ± 0.8 SD

n.d.

<0.01

0.886

0.836-0.953

2.6–2.85

ALI/ARDS

0.9

0.95

  1. ALI acute lung injury, ARDS acute respiratory distress syndrome, AUC area under the curve, BAL bronchoalveolar lavage, CPE cardiogenic pulmonary edema, CCP Clara cell protein, CRP C-reactive protein, ELF epithelial lining fluid, EVWI extravascular lung water index, HTI56 human type I cell-specific apical membrane protein, KGF keratinocyte growth factor, n.d. not described, n.s. not significant, PEF pulmonary edema fluid, PMN polymorphonuclear neutrophils, PVPI pulmonary vascular permeability index, s-Cath suction catheter, SD standard deviation, SEM standard error of the mean, SP-A surfactant Protein-A, SP-B surfactant protein-B
  2. ***Good, or *poor quality assessed based on biases using the modified Hayden’s criteria